The development and characterization of a long acting anti‐thrombotic von Willebrand factor (VWF) aptamer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The development and characterization of a long acting anti‐thrombotic von Willebrand factor (VWF) aptamer

Published:2020-03-05 Issue:5 Volume:18 Page:1113-1123
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Zhu Shuhao¹,Gilbert James C.¹,Hatala Paul²,Harvey Warren³,Liang Zicai⁴,Gao Shan⁴,Kang Daiwu⁴,Jilma Bernd⁵^ORCID

Affiliation:

1. Guardian Therapeutics Inc Lexington Massachusetts USA

2. pHatala Consulting Medford Massachusetts USA

3. ICON Clinical Research Dublin Ireland

4. Suzhou Ribo Life Science Co., Ltd Kunshan City China

5. Department of Clinical Pharmacology Medical University of Vienna Vienna Austria

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14755

Reference50 articles.

1. von Willebrand factor assembly and secretion

2. von Willebrand factor: the old, the new and the unknown

3. BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR

4. Relative Involvement of GPIb/IX-vWF Axis and GPIIb/IIIa in Thrombus Growth at High Shear Rates in the Guinea Pig

5. GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conformational activation and inhibition of von Willebrand factor by targeting its autoinhibitory module;Blood;2024-05-09

2. Progress in von Willebrand Disease Treatment: Evolution towards Newer Therapies;Seminars in Thrombosis and Hemostasis;2024-02-08

3. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering;Environmental Research;2023-12

4. Structural Insights into Protein–Aptamer Recognitions Emerged from Experimental and Computational Studies;International Journal of Molecular Sciences;2023-11-14

5. The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A;Blood;2023-03-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3